<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tedijanto C</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>National Eye Institute</funding><funding>NEI NIH HHS</funding><funding>Research to Prevent Blindness</funding><funding>NIAID NIH HHS</funding><pagination>e0010273</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8942265</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(3)</volume><pubmed_abstract>Trachoma is an infectious disease characterized by repeated exposures to Chlamydia trachomatis (Ct) that may ultimately lead to blindness. Efficient identification of communities with high infection burden could help target more intensive control efforts. We hypothesized that IgG seroprevalence in combination with geospatial layers, machine learning, and model-based geostatistics would be able to accurately predict future community-level ocular Ct infections detected by PCR. We used measurements from 40 communities in the hyperendemic Amhara region of Ethiopia to assess this hypothesis. Median Ct infection prevalence among children 0-5 years old increased from 6% at enrollment, in the context of recent mass drug administration (MDA), to 29% by month 36, following three years without MDA. A</pubmed_abstract><journal>PLoS neglected tropical diseases</journal><pubmed_title>Predicting future community-level ocular Chlamydia trachomatis infection prevalence using serological, clinical, molecular, and geospatial data.</pubmed_title><pmcid>PMC8942265</pmcid><funding_grant_id>UG1 EY023939</funding_grant_id><funding_grant_id>Unrestricted Grant</funding_grant_id><funding_grant_id>R03 AI147128</funding_grant_id><funding_grant_id>U10 EY023939</funding_grant_id><pubmed_authors>Tedijanto C</pubmed_authors><pubmed_authors>Arnold BF</pubmed_authors><pubmed_authors>Tadesse Z</pubmed_authors><pubmed_authors>Wittberg DM</pubmed_authors><pubmed_authors>Aragie S</pubmed_authors><pubmed_authors>Gwyn S</pubmed_authors><pubmed_authors>Haile M</pubmed_authors><pubmed_authors>Martin DL</pubmed_authors><pubmed_authors>Sturrock HJW</pubmed_authors><pubmed_authors>Nash SD</pubmed_authors><pubmed_authors>Lietman TM</pubmed_authors><pubmed_authors>Zeru T</pubmed_authors><pubmed_authors>Keenan JD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predicting future community-level ocular Chlamydia trachomatis infection prevalence using serological, clinical, molecular, and geospatial data.</name><description>Trachoma is an infectious disease characterized by repeated exposures to Chlamydia trachomatis (Ct) that may ultimately lead to blindness. Efficient identification of communities with high infection burden could help target more intensive control efforts. We hypothesized that IgG seroprevalence in combination with geospatial layers, machine learning, and model-based geostatistics would be able to accurately predict future community-level ocular Ct infections detected by PCR. We used measurements from 40 communities in the hyperendemic Amhara region of Ethiopia to assess this hypothesis. Median Ct infection prevalence among children 0-5 years old increased from 6% at enrollment, in the context of recent mass drug administration (MDA), to 29% by month 36, following three years without MDA. A</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-05-30T23:54:45.578Z</modification><creation>2025-04-04T23:32:59.491Z</creation></dates><accession>S-EPMC8942265</accession><cross_references><pubmed>35275911</pubmed><doi>10.1371/journal.pntd.0010273</doi></cross_references></HashMap>